Skip to main content
. 2021 Feb 5;14:97. doi: 10.1186/s13071-021-04600-0

Table 2.

Recommended criteria for future SCH and SCH reporting, including age categorisation

Criteria Definitions
Year(s) of study completion Year and month—relevance for seasonality in future analyses
No. of participants Overall and age/sex breakdowns
Sex ratio Overall and in each age category
Age mid-point Mean not median
Age breakdown Standardised age boundaries—age range or each year of age
Prevalence of parasites Defined numbers—number infected and/or percentage
Intensity of parasites Calculated using arithmetic not geometric mean
Co-prevalent parasites Named species found in a single sample
Diagnostic used Named method and number of replicates (slides and/or days)
Participants treated before Any exclusion criteria, e.g. anyone treated 1 month prior to study
Treatment offered Name of drug, dose, days taken. Always to be free to participant
Location of study GPS coordinates of site(s), or woreda name if privacy concerns dictate
Age groups Suggested age boundaries
 pre-SAC 0–4 Years of age
 SAC 5–14 Years of age
 Adolescents 14–21 Years of age
 Adult 22+ Years of age

GPS Global positioning system; for other abbreviations, see Table 1